Cardiometabolic Health Congress

AUGUST 14, 2024

This October, we gather for the largest and most innovative cardiometabolic event, honoring Dr. Bakris’ profound impact on our community. Singh, MBBS, FRCP, MBA Advances in Obesity Pharmacotherapy Louis J. To apply, click here or go to www.cardiometabolichealth.org/george-bakris-scholarship-program/ NEW!

CME 72

CME Education Diabetes Innovation 72

GEMMS

MAY 22, 2024

In this article, we will explore the top 10 trends shaping the future of cardiovascular medicine, highlighting the innovative technologies and approaches that are revolutionizing the field. Innovative algorithms analyze gene biomarkers to provide predictive insights and personalized patient therapy.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

DAIC

DECEMBER 19, 2023

This clinical trial cohort included participants aged 24 to 70, with diagnosed co-morbidities that included OSA, asthma, diabetes, obesity hypertension, Heart Failure (HF) and hyperthyroidism. Peerbridge Health continues to innovate by compounding clinical utility in one simple device," said Andrea Natale, M.D., David's Medical Center.

Heart Failure 52

Heart Failure Innovation Heart Disease Quality of Life 52

DAIC

FEBRUARY 29, 2024

ET Murphy Ballroom 4 Comparison of an "Inclisiran First" Strategy with Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial Targeting Weight Loss to Personalize the Prevention of Type 2 Diabetes Once-weekly Semaglutide in Patients with Heart Failure With Preserved Ejection Fraction, (..)

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

DAIC

MAY 21, 2024

Hypertension, high cholesterol, and obesity are among the most common risk factors of cardiovascular disease and mortality — but getting these risk factors under control can be very challenging,” said Edo Paz, MD , the study’s lead author and SVP, Medical Affairs, Hello Heart.

Blood Pressure 52

Blood Pressure Cholesterol Risk Factors BMI 52

Cardiometabolic Health Congress

AUGUST 2, 2023

Dr. Caballero is an endocrinologist, clinical investigator, and faculty director of International Innovation and Diabetes Education at Harvard Medical School. These conditions affect a patient’s risk of health conditions like heart disease, diabetes, and obesity. ” “But,” cautions Dr.

Education 40

Education Health Disparities Webinar Diabetes 40

Cardiometabolic Health Congress

OCTOBER 26, 2023

A session at the 18 th Annual Cardiometabolic Health Congress (CMHC), explored the intersection of cardiometabolic conditions such as obesity and insulin resistance with liver disease, beginning with some important new updates on the preferred terms for these diseases. Eckel, MD On Thursday, Oct. 78(1), pp. doi: 10.1097/hep.0000000000000412.

Diabetes 52

Diabetes Kidney Disease Obesity Anatomy 52

Wellnest

JULY 19, 2023

However, recent studies have observed that people below 40 are also experiencing heart attacks due to high blood pressure, cholesterol, diabetes, smoking, obesity, a sedentary lifestyle, and social and mental stress. Obesity or being overweight can increase the risk of heart disease. So, how do you recognize a heart attack?

Heart attacks 52

Heart attacks Heart Attack Blood Pressure Myocardial Infarction 52

Cardiometabolic Health Congress

MARCH 8, 2024

She is one of the first fellowship-trained obesity medicine physicians in the world. What we do next has the power to usher in an era of medical science where women are represented equally in scientific research, valued, and given the freedom to innovate, enhance human health, and extend lifespan.

Cardiac Rehabilitation 59

Cardiac Rehabilitation Academic Diabetes Research 59

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Attendees, including hundreds of health professionals, gained access to the latest knowledge and developments in the field, from exclusive insights from one of the foremost authorities on atherosclerosis, Dr. Peter Libby, to innovations like new therapeutic agents and exciting advancements in renal protection. In the U.S.,

CME 103

CME Obesity Heart Failure Biomarkers 103

Cardiometabolic Health Congress

NOVEMBER 22, 2024

From breakthrough medications to innovative technologies, there is a lot for cardiometabolic clinicians professionals to celebrate. Tirzepatide’s Dual Benefits in Obesity : Recent studies on tirzepatide , a GLP-1 receptor agonist, revealed significant weight loss and improved outcomes in sleep apnea patients.

Blood Pressure 59

Blood Pressure Obesity Preserved Ejection Fraction Coronary Artery Disease 59

Frontiers in Cardiovascular Medicine

FEBRUARY 18, 2025

Quantitative RT-PCR was used to quantify mtDNA-CN and mtDNA4977 deletion rate.ResultsThe EOCAD group had a higher prevalence of male gender (p<0.001), smoking (p=0.001), hypertension (p<0.001), diabetes mellitus (p=0.04) and obesity (p<0.001) than controls. EOCAD patients had lower mtDNA-CN (p<0.001) and higher mtDNA4977 deletion (p=0.026).

Coronary Artery Disease 52

Coronary Artery Disease Risk Factors Obesity Atherosclerosis 52

Dr. Malcolm Kendrick

OCTOBER 30, 2024

In the Sunday Times of April 23 rd , 2017, this article appeared, entitled ‘ Kellogg’s smothers health crisis in sugar – The cereals giant is funding studies that undermine official warnings on obesity.’ The study, published in the Journal Obesity Facts relied on evidence from 14 studies. Just to choose a few paragraphs. ‘

Cholesterol 145

Cholesterol Article Research Diet 145

Cardiometabolic Health Congress

JANUARY 2, 2025

Tirzepatide Approval Date: December 19, 2024 Indication: Moderate to severe obstructive sleep apnea (OSA) in adults with obesity, combined with a reduced-calorie diet and increased physical activity. By prioritizing patient-centric innovation, these advancements emphasize the importance of addressing unmet medical needs.

Coronary Artery Disease 52

Coronary Artery Disease Stents Stent Innovation 52